Market Cap 76.96B
Revenue (ttm) 177.01B
Net Income (ttm) 5.98B
EPS (ttm) N/A
PE Ratio 11.25
Forward PE 11.52
Profit Margin 3.38%
Debt to Equity Ratio 0.68
Volume 1,318,300
Avg Vol 2,034,668
Day's Range N/A - N/A
Shares Out 222.24M
Stochastic %K 35%
Beta 0.59
Analysts Strong Sell
Price Target $376.84

Company Profile

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products...

Industry: Healthcare Plans
Sector: Healthcare
Phone: 833 401 1577
Address:
220 Virginia Avenue, Indianapolis, United States
JohnAnthony_
JohnAnthony_ Oct. 24 at 6:52 PM
$CNC $ELV $MOH $OSCR $UNH And take 1 fuckin guess what this is gonna do to UNH? Hahahaha jesus christ its called generational wealth…cum cum get you sum 🤣🤣
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 24 at 6:37 PM
$ELV Share Price: $344.00 Contract Selected: Mar 20, 2026 $340 Calls Buy Zone: $26.69 – $32.97 Target Zone: $46.23 – $56.50 Potential Upside: 64% ROI Time to Expiration: 146 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 24 at 6:01 PM
1 · Reply
ggoggo
ggoggo Oct. 24 at 5:18 PM
$ELV Why selling off now?
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 24 at 2:02 PM
Enter: $ELV NOV 21 2025 $350 CALLS Buy in Price: $11.80 - $12.10 Take Profit: $27.49 Stop Bleeding: $10.38 ROI Potential: 133% https://moneygroup.us/
0 · Reply
flywithfitz81
flywithfitz81 Oct. 24 at 1:20 PM
$CNC $MOH $ELV $UNH $CVS Ratings Upgrades for all! Centene $40 Price Target Mizuho CVS $88 UNH $430 ELV $420 HUM $345 'Mizuho Securities raised price targets on several large U.S. health insurers following the release of the latest Medicare Advantage star ratings, noting improved visibility into earnings. Analyst Ann Hynes raised her target on CVS Health to $88 from $76, UnitedHealth to $430 from $300, Elevance Health to $420 from $342 and Humana to $345 from $300 and maintained an 'Outperform' rating on all four stocks. The firm also lifted Centene’s target to $40 from $28 with a 'Neutral' rating.' https://stocktwits.com/news-articles/markets/equity/cvs-united-health-elevance-humana-gain-price-target-hikes-wall-street-after-medicare-star-ratings-update/ch6aSgIR31Q
1 · Reply
flywithfitz81
flywithfitz81 Oct. 24 at 7:18 AM
$CNC $37 by Monday. The Data from $ELV shows Medicaid is the winning insurance segment to be in right now. Centene has the highest share of Medicaid enrollees.
0 · Reply
flywithfitz81
flywithfitz81 Oct. 24 at 7:16 AM
$CNC $DIA $SPY $MOH $ELV Centene sees $37 today. Medicaid is actually the upside for insurers. Great news! 'Elevance Health Stock To Rally 10%? Analyst Sees Upside After Q3 Print, Retail Bulls Feel It’s ‘Time To Buy’ ' https://stocktwits.com/news-articles/markets/equity/elevance-health-stock-to-rally-10-analyst-sees-upside-after-q3-print/cLGJfDVR3s3
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 24 at 5:12 AM
Elevance Health Stock To Rally 10%? Analyst Sees Upside After Q3 Print, Retail Bulls Feel It’s ‘Time To Buy’ $ELV https://stocktwits.com/news/equity/markets/elevance-health-stock-to-rally-10-analyst-sees-upside-after-q3-print/cLGJfDVR3s3
0 · Reply
Ydanny
Ydanny Oct. 24 at 3:22 AM
$ELV $MOH $UNH The full picture matters. The margin compression you’re citing was already telegraphed as a temporary mix effect from higher utilization in early ’25. Management explicitly said in both the Q2 call and guidance update that medical cost trends are stabilizing, with sequential improvement expected in the back half of the year and continuing into ’26 as value-based contracts ramp and Optum Health transitions more patients under risk. Optum’s revenue growth remains double digits Y/Y across the enterprise — Insight up mid-teens, Rx high single to low double digits, Health poised to reaccelerate. The 430bps rise in care ratio isn’t structural — it’s cyclical normalization following post-COVID deferred care and Medicaid redeterminations. $UNH reaffirmed full-year EPS and long-term 13–16% growth guidance — that’s not a company facing “margin collapse.” It’s a company absorbing short-term volatility while maintaining industry-leading profitability and scale.
2 · Reply
Latest News on ELV
Elevance: Checking Out The Q3 Report

Oct 22, 2025, 7:12 AM EDT - 3 days ago

Elevance: Checking Out The Q3 Report


Elevance Health, Inc. (ELV) Q3 2025 Earnings Call Transcript

Oct 21, 2025, 11:54 AM EDT - 3 days ago

Elevance Health, Inc. (ELV) Q3 2025 Earnings Call Transcript


Elevance Health Quarterly Profit Climbs as Memberships Slip

Oct 21, 2025, 7:27 AM EDT - 4 days ago

Elevance Health Quarterly Profit Climbs as Memberships Slip


Elevance Health Reports Third Quarter 2025 Results

Oct 21, 2025, 6:00 AM EDT - 4 days ago

Elevance Health Reports Third Quarter 2025 Results


Elevance Health - Piggy Bank Or Headache?

Aug 21, 2025, 5:46 PM EDT - 2 months ago

Elevance Health - Piggy Bank Or Headache?


Elevance Health loses bid to challenge US Medicare star ratings

Aug 19, 2025, 12:49 PM EDT - 2 months ago

Elevance Health loses bid to challenge US Medicare star ratings


3 SWANs On Sale

Aug 8, 2025, 7:00 AM EDT - 2 months ago

3 SWANs On Sale

BMY REXR


Elevance Health: CEO Buys As CareBridge Drives Strong Growth

Jul 24, 2025, 12:16 PM EDT - 3 months ago

Elevance Health: CEO Buys As CareBridge Drives Strong Growth


Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More

Jul 17, 2025, 1:25 PM EDT - 3 months ago

Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More

CSX PEP


Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript

Jul 17, 2025, 11:23 AM EDT - 3 months ago

Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript


Elevance cuts annual profit forecast on high medical costs

Jul 17, 2025, 6:12 AM EDT - 3 months ago

Elevance cuts annual profit forecast on high medical costs


Elevance Health Reports Second Quarter 2025 Results

Jul 17, 2025, 6:00 AM EDT - 3 months ago

Elevance Health Reports Second Quarter 2025 Results


Elevance Health: Much Cheaper Than UNH, Yet No Drama

Jul 16, 2025, 2:19 PM EDT - 3 months ago

Elevance Health: Much Cheaper Than UNH, Yet No Drama


Top 15 High-Growth Dividend Stocks For July 2025

Jul 1, 2025, 9:02 PM EDT - 4 months ago

Top 15 High-Growth Dividend Stocks For July 2025

APH BAC BK DKS DPZ GPN IEX


JohnAnthony_
JohnAnthony_ Oct. 24 at 6:52 PM
$CNC $ELV $MOH $OSCR $UNH And take 1 fuckin guess what this is gonna do to UNH? Hahahaha jesus christ its called generational wealth…cum cum get you sum 🤣🤣
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 24 at 6:37 PM
$ELV Share Price: $344.00 Contract Selected: Mar 20, 2026 $340 Calls Buy Zone: $26.69 – $32.97 Target Zone: $46.23 – $56.50 Potential Upside: 64% ROI Time to Expiration: 146 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 24 at 6:01 PM
1 · Reply
ggoggo
ggoggo Oct. 24 at 5:18 PM
$ELV Why selling off now?
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 24 at 2:02 PM
Enter: $ELV NOV 21 2025 $350 CALLS Buy in Price: $11.80 - $12.10 Take Profit: $27.49 Stop Bleeding: $10.38 ROI Potential: 133% https://moneygroup.us/
0 · Reply
flywithfitz81
flywithfitz81 Oct. 24 at 1:20 PM
$CNC $MOH $ELV $UNH $CVS Ratings Upgrades for all! Centene $40 Price Target Mizuho CVS $88 UNH $430 ELV $420 HUM $345 'Mizuho Securities raised price targets on several large U.S. health insurers following the release of the latest Medicare Advantage star ratings, noting improved visibility into earnings. Analyst Ann Hynes raised her target on CVS Health to $88 from $76, UnitedHealth to $430 from $300, Elevance Health to $420 from $342 and Humana to $345 from $300 and maintained an 'Outperform' rating on all four stocks. The firm also lifted Centene’s target to $40 from $28 with a 'Neutral' rating.' https://stocktwits.com/news-articles/markets/equity/cvs-united-health-elevance-humana-gain-price-target-hikes-wall-street-after-medicare-star-ratings-update/ch6aSgIR31Q
1 · Reply
flywithfitz81
flywithfitz81 Oct. 24 at 7:18 AM
$CNC $37 by Monday. The Data from $ELV shows Medicaid is the winning insurance segment to be in right now. Centene has the highest share of Medicaid enrollees.
0 · Reply
flywithfitz81
flywithfitz81 Oct. 24 at 7:16 AM
$CNC $DIA $SPY $MOH $ELV Centene sees $37 today. Medicaid is actually the upside for insurers. Great news! 'Elevance Health Stock To Rally 10%? Analyst Sees Upside After Q3 Print, Retail Bulls Feel It’s ‘Time To Buy’ ' https://stocktwits.com/news-articles/markets/equity/elevance-health-stock-to-rally-10-analyst-sees-upside-after-q3-print/cLGJfDVR3s3
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 24 at 5:12 AM
Elevance Health Stock To Rally 10%? Analyst Sees Upside After Q3 Print, Retail Bulls Feel It’s ‘Time To Buy’ $ELV https://stocktwits.com/news/equity/markets/elevance-health-stock-to-rally-10-analyst-sees-upside-after-q3-print/cLGJfDVR3s3
0 · Reply
Ydanny
Ydanny Oct. 24 at 3:22 AM
$ELV $MOH $UNH The full picture matters. The margin compression you’re citing was already telegraphed as a temporary mix effect from higher utilization in early ’25. Management explicitly said in both the Q2 call and guidance update that medical cost trends are stabilizing, with sequential improvement expected in the back half of the year and continuing into ’26 as value-based contracts ramp and Optum Health transitions more patients under risk. Optum’s revenue growth remains double digits Y/Y across the enterprise — Insight up mid-teens, Rx high single to low double digits, Health poised to reaccelerate. The 430bps rise in care ratio isn’t structural — it’s cyclical normalization following post-COVID deferred care and Medicaid redeterminations. $UNH reaffirmed full-year EPS and long-term 13–16% growth guidance — that’s not a company facing “margin collapse.” It’s a company absorbing short-term volatility while maintaining industry-leading profitability and scale.
2 · Reply
BazingAC
BazingAC Oct. 24 at 3:19 AM
$UNH $ELV $MOH Alright man, gonna call you out on this one.. MARGINS: the earnings release shows that quarter over quarter and year over year margins are compressing... For the company as a whole and each segment (united healtcare and Optum) margins are compressing. Your post says the exact opposite, pls share your source, mine is UNH earnings release, link below Medical Cost and Utilization: read bottom of page 4 of ER (again link below) medical cost trend in '25 is 7.5%, and expected to accelerate to 10% in '26. On page 2 the company disclosed a 430bps yoy increase in medical care ratio.. where is the evidence of peak utilization and peak costs? Aside from your (or my opinion), can we share anything of substance, something based on fact or evidence? Dont worry, i wont reply to another opinion based post. Cheers https://www.unitedhealthgroup.com/content/dam/UHG/PDF/investors/2025/unh-reestablishes-full-year-outlook-and-reports-second-quarter-2025-results.pdf
1 · Reply
Ydanny
Ydanny Oct. 24 at 2:30 AM
$UNH Everyone keeps trying to lump $UNH in with $ELV and $MOH — but they’re not even in the same league. $UNH isn’t just an insurer; it’s a diversified healthcare ecosystem. Optum now drives more than half of total earnings, margins are expanding again, and utilization has already peaked. The company’s guidance into 2026 points to accelerating EPS and record free cash flow. Heading into earnings, sentiment is overly cautious while fundamentals have never been stronger. This isn’t a “managed care” story — it’s a healthcare infrastructure story. $UNH is built different.
0 · Reply
BazingAC
BazingAC Oct. 24 at 1:33 AM
$UNH If options are any indication implied 1day earnings move = 5.84% (as of tonight), so from here $360 its either 381 or 338 (all else equal) Options positioning for the Oct 31 expiry shows that 5 of the top 6 listed contracts by open interest are PUTS (screenshot 1) and even more important implied volatility to the DOWNSIDE (80% strike) is more expensive that to the upside (120% strike) (screenshot 2), google "volatility skew" to learn more For a trade, the Oct 31 $340 PUT is around $4.75, with an implied vol of 58% and a delta of 25, either as a partial hedge(if you are bullish) or a speculative short (if you are bearish) I know it seems like ages ago but on 7/28 (right before earnings) the stock was sitting at $282 with market expecting reinstated guidance of $18+ (instead we got $16+)... today we are $80 higher, thats 4.5 more turns in p/e ratio, after $ELV and $MOH i am leaning bearish and looking to position that way.. if i burn premium, so be it. Good luck bulls
2 · Reply
flywithfitz81
flywithfitz81 Oct. 23 at 8:38 PM
$CNC $UNH $MOH $ELV $CVS Resolution nearing: We have us a couple sticking points which will likely be resolved to end the shutdown: 1) Immigrants Coverage: increased scrutiny and prohibition of illegal immigrants enrolling. Increased theft and abuse verification systems. (already in place, but whatever) 2) House Energy and Commerce Chair Brett Guthrie warned in an interview Tuesday that any extension would “absolutely” need to include a crackdown on so-called “phantom” Obamacare enrollees. The move is sure to spark a clash with Democrats, who successfully challenged similar provisions from Guthrie’s committees when they were included in the GOP megabill that passed over the summer. But now Republicans have more leverage as Democrats push for the continuation of tax credits that are set to expire Dec. 31. “If there’s going to be an extension of those tax credits, the program integrity stuff … absolutely needs to be in place,” Guthrie said. https://www.politico.com/live-updates/2025/10/23/congress/brett-guthrie-obamacare-auto-enrollees-00620622 https://www.politico.com/newsletters/new-york-playbook/2025/10/02/a-closer-look-at-the-gops-shutdown-attack-00591385
1 · Reply
Hrumph63
Hrumph63 Oct. 23 at 4:15 PM
$ELV Cmon ELVis. Shake it up a lil baby..
0 · Reply
JarvisFlow
JarvisFlow Oct. 23 at 3:22 PM
TD Cowen updates rating for Elevance Health ( $ELV ) to Buy, target set at 330 → 380.
0 · Reply
senseidragon
senseidragon Oct. 23 at 3:07 PM
$HCA this is gonna dump just like $MOH $ELV on er
1 · Reply
312bunny
312bunny Oct. 23 at 2:19 PM
$OSCR recent earnings $ELV and $MOH cleary shows it wasn’t priced in. There is a negative sentiment price wise and also outlook wise for 2026. $UNH and $CNC are reporting next week. Those will be bad as well. Look at the dashboard. Growth / enrollment is down for 2026.
3 · Reply
thezat
thezat Oct. 23 at 2:07 PM
$ELV shit I missed my put exit.
0 · Reply
FallingKnifeVictim
FallingKnifeVictim Oct. 23 at 1:43 PM
$ELV naysayers be damned, this is a very well operated health care insurer that will flourish in the upcoming correction.
0 · Reply
cubie
cubie Oct. 23 at 1:39 PM
$CNC $MOH $UNH $ELV $HUM Congrats centene and molina giddy bears🤗😁
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 23 at 1:21 PM
Enter: $ELV NOV 21 2025 $350 CALLS Buy in Price: $11.50 - $12.08 Take Profit: $16.10 Stop Bleeding: $10.12 ROI Potential: 40% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply